MindWalk Holdings (HYFT) Inventory Average (2021 - 2026)
MindWalk Holdings (HYFT) posted quarterly Inventory Average of $355998.1 for Q2 2026, down 74.79% year-over-year from $1.4 million in Q2 2025, and down 3.24% quarter-over-quarter from $367933.0 in Q1 2026.
MindWalk Holdings (HYFT) Inventory Average (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Inventory Average for 6 consecutive years, with $355998.1 the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average fell 74.79% year-over-year to $355998.1; the TTM figure through Apr 2026 stood at $355998.1 (down 74.79% YoY), while the FY2026 annual figure was $931445.4, down 39.69% from the prior year.
- Inventory Average slipped to $355998.1 in Q2 2026 per HYFT's latest filing, from $367933.0 in the prior quarter.
- Across five years, Inventory Average topped out at $1.8 million in Q1 2024 and bottomed at $355998.1 in Q2 2026.
- Historically, Inventory Average has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2024 — Inventory Average jumped 45.29% — and 2026, when it slumped 74.79%.
- MindWalk Holdings' Inventory Average stood at $1.2 million in 2022, then surged by 44.54% to $1.7 million in 2023, then slipped by 18.14% to $1.4 million in 2024, then slumped by 73.06% to $382073.1 in 2025, then decreased by 6.82% to $355998.1 in 2026.
- Business Quant data shows HYFT's Inventory Average at $355998.1 in Q2 2026, $367933.0 in Q1 2026, and $382073.1 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 355,998.06 |
| Jan 31, 2026 | 367,932.95 |
| Oct 31, 2025 | 382,073.13 |
| Jul 31, 2025 | 926,788.06 |
| Apr 30, 2025 | 1.41 Mn |
| Jan 31, 2025 | 1.41 Mn |
| Oct 31, 2024 | 1.42 Mn |
| Jul 31, 2024 | 1.47 Mn |
| Apr 30, 2024 | 1.73 Mn |
| Jan 31, 2024 | 1.84 Mn |
| Oct 31, 2023 | 1.73 Mn |
| Jul 31, 2023 | 1.59 Mn |
| Apr 30, 2023 | 1.43 Mn |
| Jan 31, 2023 | 1.27 Mn |
| Oct 31, 2022 | 1.20 Mn |
| Jul 31, 2022 | 1.24 Mn |
| Apr 30, 2022 | 1.24 Mn |
| Jan 31, 2022 | 1.11 Mn |
| Oct 31, 2021 | 1.03 Mn |
| Jul 31, 2021 | 1.01 Mn |